Herbalife concluded 2025 with strong momentum, achieving Q4 net sales of $1.3 billion, a 6.3% year-over-year increase, and adjusted EBITDA of $156.1 million, exceeding guidance. The company also saw significant new distributor growth in North America and Latin America, alongside a strategic investment from Cristiano Ronaldo in its Pro2col technology.

Herbalife reported strong first quarter 2025 results, with net sales of $1.2 billion at the midpoint of guidance and adjusted EBITDA of $164.9 million, exceeding expectations. The company also raised its full-year 2025 adjusted EBITDA expectations and reduced its total leverage ratio to 3.0x.

Herbalife reported fourth quarter 2024 net sales of $1.2 billion, a slight decrease of 0.6% year-over-year, but an increase of 2.7% on a constant currency basis. Adjusted EBITDA of $150.0 million exceeded guidance, with the adjusted EBITDA margin up 340 basis points compared to Q4 2023. Diluted EPS was $1.74, and adjusted diluted EPS was $0.36.

Herbalife's third quarter 2024 results showed net sales of $1.2 billion, a decrease of 3.2% year-over-year, but an improvement in gross profit margin to 78.3%. Net income was $47.4 million, and adjusted EBITDA was $166.5 million. The company realized savings from its Restructuring Program and completed the sale and leaseback of its Torrance office building.

Herbalife reported a 2.5% decrease in net sales, totaling $1.3 billion, but achieved growth on a constant currency basis. The adjusted EBITDA of $180.0 million exceeded expectations, with a margin increase of 120 basis points year-over-year. The company is focused on driving shareholder value and reducing total leverage.

Herbalife reported a 1.0% year-over-year increase in net sales to $1.3 billion for Q1 2024. The company's adjusted EBITDA exceeded guidance, driven by cost reductions.

Herbalife reported Q4 2023 net sales of $1.2 billion, a 2.9% increase year-over-year. Net income was $10.2 million, and diluted EPS was $0.10. The company realized $27 million in cost savings related to its Transformation Program and expects further savings in 2024.

Herbalife reported Q3 2023 net sales of $1.3 billion, a 1.1% decrease year-over-year. Net income was $42.8 million, and diluted EPS was $0.43. The company is on track to achieve year-over-year net sales growth in the fourth quarter.

Herbalife reported a 5.7% decrease in net sales to $1.3 billion for Q2 2023. Despite the sales decline, gross profit margin improved, and the company's Transformation Program is expected to deliver increased cost savings. The company reported net income of $59.9 million and adjusted EBITDA of $169.6 million.

Herbalife reported a decrease in net sales by 6.3% to $1.3 billion compared to Q1 2022. Net income was $29.3 million, and adjusted diluted EPS was $0.54. The company is focusing on its Transformation Program to drive productivity and has amended its Senior Secured Credit Facility for greater financial flexibility.

Herbalife Nutrition reported Q4 2022 net sales of $1.2 billion, a 10.4% decrease compared to Q4 2021. The company's reported diluted EPS was $0.55, and adjusted diluted EPS was $0.53. Macroeconomic inflationary pressures continued to challenge operations and customer demand during the quarter.

Herbalife Nutrition reported a decrease in net sales by 9.5% to $1.3 billion compared to Q3 2021. The company reported diluted EPS of $0.83 and adjusted diluted EPS of $0.91. Due to macroeconomic conditions, Herbalife withdrew its full year 2022 guidance. Michael O. Johnson was announced as Chairman and interim CEO.

Herbalife Nutrition reported Q2 2022 net sales of $1.4 billion, a 10.3% decrease compared to Q2 2021, but exceeded guidance for net sales, adjusted EBITDA, and adjusted EPS. The company is reaffirming its full year 2022 guidance for net sales and adjusted EBITDA, while lowering adjusted diluted full year 2022 EPS guidance due to unfavorable currency movement.

Herbalife Nutrition reported a decrease in net sales by 11% compared to Q1 2021, with net sales of $1.3 billion. Reported EPS was $0.96, and adjusted EPS was $0.99, at the high end of the company's guidance range. The company is updating its full year outlook, lowering net sales guidance to a range of down 10.0% to down 4.0%.

Herbalife Nutrition reported a decrease in net sales for the fourth quarter of 2021 compared to the same period in 2020, but the company saw growth on a two-year stack basis and continued growth in the Indian market. The company is initiating FY 2022 net sales guidance range of 0% - 6% growth.

Herbalife Nutrition reported Q3 2021 financial results with net sales of $1.4 billion, a 6% decrease compared to Q3 2020, but in line with guidance. Diluted EPS was $1.09, and adjusted diluted EPS was $1.21. The company exceeded the high-end of its guidance range for adjusted diluted EPS and adjusted EBITDA and is reiterating its FY 2021 outlook.

Herbalife Nutrition reported a strong second quarter with net sales of $1.6 billion, a 15% increase compared to Q2 2020. Adjusted EBITDA reached a record $262.1 million, and the company updated its full-year guidance for net sales and adjusted diluted EPS.

Herbalife Nutrition reported record first quarter net sales of $1.5 billion, an 18.9% increase compared to the first quarter 2020. The company raised its full year 2021 net sales guidance to 9.0% to 15.0% growth and raised its reported and adjusted diluted EPS guidance.

Herbalife Nutrition reported record-breaking 2020 net sales with a 14% increase compared to the prior year. The company's Q4 net sales reached $1.4 billion, representing the largest fourth-quarter net sales result in company history. Reported diluted EPS for Q4 2020 was $0.59, while adjusted diluted EPS was $0.71. The company raised its FY 2021 net sales and EPS guidance and announced a new $1.5 billion share repurchase program.

Herbalife Nutrition reported record-breaking net sales of $1.5 billion for Q3 2020, a 22.3% increase compared to Q3 2019, driven by consumer interest in health and wellness.

Herbalife Nutrition reported record net sales of $1.3 billion for the second quarter of 2020, an increase of 8.6% compared to the second quarter of 2019. The company's diluted EPS was $0.82, and adjusted EPS was $0.95 per diluted share.

Herbalife Nutrition reported a strong first quarter, marked by record volume points and increased net sales. Despite challenges, the company demonstrated resilience and growth in key regions.

Herbalife Nutrition reported a 2.8% increase in net sales for the fourth quarter of 2019, reaching $1.2 billion. Diluted EPS was $0.40, and adjusted EPS was $0.74. Full year volume points increased 3.0% compared to 2018, representing the largest annual volume point result in company history.